These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 27352629)
21. Assessment of postmenopausal women and significant risk factors for osteoporosis. Schnatz PF; Marakovits KA; O'Sullivan DM Obstet Gynecol Surv; 2010 Sep; 65(9):591-6. PubMed ID: 21144090 [TBL] [Abstract][Full Text] [Related]
22. One-year clinical outcome in patients with acute coronary syndrome treated with concomitant use of clopidogrel and proton pump inhibitors: results from a regional cohort study. Ortolani P; Marino M; Marzocchi A; De Palma R; Branzi A J Cardiovasc Med (Hagerstown); 2012 Dec; 13(12):783-9. PubMed ID: 21252697 [TBL] [Abstract][Full Text] [Related]
23. Gastric acid suppression by proton pump inhibitors as a risk factor for clostridium difficile-associated diarrhea in hospitalized patients. Aseeri M; Schroeder T; Kramer J; Zackula R Am J Gastroenterol; 2008 Sep; 103(9):2308-13. PubMed ID: 18702653 [TBL] [Abstract][Full Text] [Related]
24. Proton pump inhibitors and risk of periampullary cancers--A nested case-control study. Chien LN; Huang YJ; Shao YH; Chang CJ; Chuang MT; Chiou HY; Yen Y Int J Cancer; 2016 Mar; 138(6):1401-9. PubMed ID: 26488896 [TBL] [Abstract][Full Text] [Related]
25. Poor Socioeconomic and Nutritional Status Are Associated with Osteoporosis in Korean Postmenopausal Women: Data from the Fourth Korea National Health and Nutrition Examination Survey (KNHANES) 2009. Kim MH; Lee JS; Johnson MA J Am Coll Nutr; 2015; 34(5):400-7. PubMed ID: 25826107 [TBL] [Abstract][Full Text] [Related]
26. Proton Pump Inhibitor Use and Risk of Hip Fracture in Kidney Transplant Recipients. Lenihan CR; Sukumaran Nair S; Vangala C; Ramanathan V; Montez-Rath ME; Winkelmayer WC Am J Kidney Dis; 2017 May; 69(5):595-601. PubMed ID: 27866965 [TBL] [Abstract][Full Text] [Related]
27. Proton pump inhibitor use significantly increases the risk of cryptogenic liver abscess: a population-based study. Wang YP; Liu CJ; Chen TJ; Lin YT; Fung CP Aliment Pharmacol Ther; 2015 Jun; 41(11):1175-81. PubMed ID: 25871643 [TBL] [Abstract][Full Text] [Related]
28. [Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures?]. Thorsdottir G; Benedikz E; Thorgeirsdottir SA; Johannsson M Laeknabladid; 2017 Mai; 103(5):231-235. PubMed ID: 28489008 [TBL] [Abstract][Full Text] [Related]
29. Is there a relationship between hypomagnesemia and proton-pump inhibitors in patients on chronic hemodialysis? Mikolasevic I; Milic S; Stimac D; Zaputovic L; Lukenda Zanko V; Gulin T; Jakopcic I; Klaric D; Gulin M; Orlic L Eur J Intern Med; 2016 May; 30():99-103. PubMed ID: 26905320 [TBL] [Abstract][Full Text] [Related]
30. Osteoporosis in Gastrointestinal Diseases. Krela-Kaźmierczak I; Szymczak A; Łykowska-Szuber L; Eder P; Linke K Adv Clin Exp Med; 2016; 25(1):185-90. PubMed ID: 26935513 [TBL] [Abstract][Full Text] [Related]
31. Co-prescribing of proton pump inhibitors among chronic users of NSAIDs in the UK. Suh DC; Hunsche E; Shin HC; Mavros P Rheumatology (Oxford); 2008 Apr; 47(4):458-63. PubMed ID: 18263598 [TBL] [Abstract][Full Text] [Related]
32. Proton pump inhibitor use represents an independent risk factor for myocardial infarction. Shih CJ; Chen YT; Ou SM; Li SY; Chen TJ; Wang SJ Int J Cardiol; 2014 Nov; 177(1):292-7. PubMed ID: 25499395 [TBL] [Abstract][Full Text] [Related]
33. Can proton pump inhibitors reduce rebleeding following Histoacryl sclerotherapy for gastric variceal hemorrhage? Kim KR; Jun CH; Cho KM; Wi JW; Park SY; Cho SB; Lee WS; Park CH; Joo YE; Kim HS; Choi SK; Rew JS Korean J Intern Med; 2015 Sep; 30(5):593-601. PubMed ID: 26354053 [TBL] [Abstract][Full Text] [Related]
34. Determination of osteoporosis risk factors using a multiple logistic regression model in postmenopausal Turkish women. Akkus Z; Camdeviren H; Celik F; Gur A; Nas K Saudi Med J; 2005 Sep; 26(9):1351-9. PubMed ID: 16155647 [TBL] [Abstract][Full Text] [Related]
35. Use of proton pump inhibitors with lack of diagnostic indications in 22 Midwestern US skilled nursing facilities. Patterson Burdsall D; Flores HC; Krueger J; Garretson S; Gorbien MJ; Iacch A; Dobbs V; Homa T J Am Med Dir Assoc; 2013 Jun; 14(6):429-32. PubMed ID: 23583000 [TBL] [Abstract][Full Text] [Related]
36. Proton Pump Inhibitors and the Risk for Hospital-Acquired Clostridium difficile Infection. Barletta JF; El-Ibiary SY; Davis LE; Nguyen B; Raney CR Mayo Clin Proc; 2013 Oct; 88(10):1085-90. PubMed ID: 24012413 [TBL] [Abstract][Full Text] [Related]
37. Risk factors for clinical fractures among postmenopausal women: a 10-year prospective study. van Geel TA; Geusens PP; Nagtzaam IF; van der Voort DJ; Schreurs CM; Rinkens PE; Dinant GJ Menopause Int; 2007 Sep; 13(3):110-5. PubMed ID: 17785036 [TBL] [Abstract][Full Text] [Related]
38. The relationship between back pain and future vertebral fracture in postmenopausal women. Kuroda T; Shiraki M; Tanaka S; Shiraki Y; Narusawa K; Nakamura T Spine (Phila Pa 1976); 2009 Aug; 34(18):1984-9. PubMed ID: 19680106 [TBL] [Abstract][Full Text] [Related]
39. Proton pump inhibitors increase the risk for hospital-acquired Clostridium difficile infection in critically ill patients. Barletta JF; Sclar DA Crit Care; 2014 Dec; 18(6):714. PubMed ID: 25540023 [TBL] [Abstract][Full Text] [Related]
40. Risk of low bone mineral density associated with psychotropic medications and mental disorders in postmenopausal women. Bolton JM; Targownik LE; Leung S; Sareen J; Leslie WD J Clin Psychopharmacol; 2011 Feb; 31(1):56-60. PubMed ID: 21192144 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]